OrthoFX(TM) Receives FDA Clearance for NiTime(TM) Aligners
NiTime Aligner is the first FDA cleared aligner system for night only wear
OrthoFX will introduce NiTime Aligner at the American Association of Orthodontists Annual Meeting, Chicago, April 21-25, 2023
FREMONT, Calif., April 17, 2023 -- (Healthcare Sa... Devices, Dental, FDA OrthoFX, NiTime Aligner, orthodontic aligner (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2023 Category: Pharmaceuticals Source Type: news
Soligenix Provides Regulatory Update on HyBryte(TM)
PRINCETON, N.J., April 14, 2023 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where ... Biopharmaceuticals, Oncology, FDA Soligenix, HyBryte, synthetic hypericin sodium, CTCL (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2023 Category: Pharmaceuticals Source Type: news
BioVentrix(R) Closes $48.5 Million Series A Financing
Financing led by Andera Partners including Cormorant Asset Management, Taglich Brothers Inc., Squarepoint Capital, and Richmond Brothers to Support Premarket Approval of Revivent TC® System for Patients with Ischemic Heart Failure
MANSFIELD, Mass., ... Devices, Interventional, Cardiology, Venture Capital BioVentrix, Revivent TC, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2023 Category: Pharmaceuticals Source Type: news
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Proceeds to Fund Expansion of Phase 1b/2a Trial of Personalized Therapeutic Cancer Vaccine in Liver Cancer
Financing adds 3B Future Health Fund to Investor Syndicate and Dr. Roberto DePonti as Board Observer
PLYMOUTH MEETING, Pa., April 12, 2023 -- ... Biopharmaceuticals, Oncology, Venture Capital Geneos Therapeutics, personalized therapeutic cancer vaccines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2023 Category: Pharmaceuticals Source Type: news
Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Schaefer Comes to Kyowa Kirin from Takeda where he served as Senior Vice President, Neuroscience Business Unit and Head of Commercial Operations, U.S. Business Unit
BEDMINSTER, N.J., April 11, 2023 -- (Healthcare Sales & Marketing Network) -- Kyowa Kir... Biopharmaceuticals, Personnel Kyowa Kirin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2023 Category: Pharmaceuticals Source Type: news
Reach Neuro Receives FDA Breakthrough Device Designation for Device to Restore Arm and Hand Movement to Chronic Stroke Patients
Reach Neuro's Avantis device delivers small electrical impulses to the spinal cord to help stroke survivors regain motion and independence
PITTSBURGH, April 10, 2023 -- (Healthcare Sales & Marketing Network) -- Reach Neuro, Inc., a neurotechnology comp... Devices, Neurology, FDA Reach Neuro, Avantis, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2023 Category: Pharmaceuticals Source Type: news
Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT(R)
QUEBEC CITY, April 6, 2023 -- (Healthcare Sales & Marketing Network) -- Icentia Inc., today announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies on a wire free, single-use record... Devices, Cardiology, FDA Icentia Inc, CardioSTAT, continuous ECG monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2023 Category: Pharmaceuticals Source Type: news
Abyrx Receives Additional FDA Clearances for MONTAGE(R) Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement
STAMFORD, Conn., April 5, 2023 -- (Healthcare Sales & Marketing Network) -- Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for use during surgical procedures, today announced its receipt of ... Devices, FDA Abyrx Inc, MONTAGE Settable, Bone Putty, cranial bone cement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2023 Category: Pharmaceuticals Source Type: news
Study Finds ZEPTO Precision Pulse Capsulotomy Offers Significant Advantages Over Manual Capsulorhexis in Treating White Cataracts
CARLSBAD, Calif., April 4, 2023 -- (Healthcare Sales & Marketing Network) -- Centricity Vision Inc., a global ophthalmic technology company and developer of the ZEPTO IOL Positioning System, today announced that a new study published in the Journal of Ca... Devices, Ophthalmology Centricity Vision, ZEPTO IOL Positioning System, Precision Pulse Capsulotomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2023 Category: Pharmaceuticals Source Type: news
Laborie Launches alpHaONE, an Innovative GERD Diagnostic System
The addition of the alpHaONE wireless pH-capsule reflux testing system furthers Laborie's commitment to advancing diagnostic solutions for esophageal diseases and expands the Gastroenterology Motility and Reflux Portfolio.
PORTSMOUTH, N.H., April 3, 202... Devices, Gastroenterology, Product Launch Laborie Medical Technologies, alpHaONE system, GERD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2023 Category: Pharmaceuticals Source Type: news
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy
Leeds Teaching Hospitals NHS Trust, (UK) Performs Non-Invasive Histotripsy in Patient with Primary Solid Renal Tumor
MINNEAPOLIS, March 30, 2023 -- (Healthcare Sales & Marketing Network) -- HistoSonics, (www.histosonics.com), the developer of a non-inv... Devices, Oncology HistoSonics, histotripsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2023 Category: Pharmaceuticals Source Type: news
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
TAMPERE, Finland, March 30, 2023 -- (Healthcare Sales & Marketing Network) -- Bioretec Ltd., a pioneer in bioresorbable[1] orthopedic implants, has today received market authorization for its RemeOs trauma screw in the U.S. The RemeOs trauma screw is th... Devices, Orthopaedic, FDA Bioretec , RemeOs , trauma screw, bioresorbable metal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2023 Category: Pharmaceuticals Source Type: news
CoreLink Announces FDA Clearance of Siber(R) Ti--3D Printed SI Joint Fusion System
ST. LOUIS, March 29, 2023 -- (Healthcare Sales & Marketing Network) -- CoreLink, LLC , a leading designer and manufacturer of innovative spinal implant systems announced today the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its S... Devices, Orthopaedic, Neurosurgery, FDA CoreLink, Siber Ti, Sacroiliac Joint Fusion, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2023 Category: Pharmaceuticals Source Type: news
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Spiral Therapeutics acquires assets from Otonomy, including data, patent rights, and inventory related to OTO-104, OTO-510, and OTO-413
Clinical data analysis suggests Spiral's lead candidate, SPT-2101, may offer improved treatment outcomes for Meniere'... Biopharmaceuticals, Acquisitions Spiral Therapeutics, Otonomy , Ménière's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2023 Category: Pharmaceuticals Source Type: news
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
BOSTON, March 28, 2023 -- (Healthcare Sales & Marketing Network) -- CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, names Adel Malek, MD PhD as the company... Devices, Neurosurgery, Personnel CereVasc , eShunt System, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 28, 2023 Category: Pharmaceuticals Source Type: news
